US Patent Issued to Immunic on May 19 for "Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases" (German Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,347, issued on May 19, was assigned to Immunic AG (Grafelfing, Germany).

"Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases" was invented by Manfred Groppel (Munich), Daniel Vitt (Germering, Germany), Hella Kohlhof (Munich) and Andreas Muhler (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to a 2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I)and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of form...